Does Dr. SHIVA ANNAMALAI have financial conflicts of interest?

Dr. SHIVA ANNAMALAI (MD) has received a total of $3,407 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $3,407 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. SHIVA ANNAMALAI?

According to CMS Open Payments data, Dr. SHIVA ANNAMALAI received funding from ABBOTT LABORATORIES ($3,247), ASTRAZENECA PHARMACEUTICALS ($116), and ABIOMED ($24).

Does Dr. SHIVA ANNAMALAI receive research grants or speaking fees?

Dr. SHIVA ANNAMALAI has received $3,407 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. SHIVA ANNAMALAI

MDReal-Time Hydrated

Specialty: Internal Medicine, Cardiovascular Disease

Practice Location: SCARBOROUGH, ME 04074

NPI Number: 1972915544

LIFETIME INDUSTRY VALUE

$3,407

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ANNAMALAI is a verified Internal Medicine, Cardiovascular Disease practitioner based in SCARBOROUGH, ME.

Between 2021 and 2024, Dr. ANNAMALAI had an overall industry promotional and research financial footprint of $3,407 as recorded in the federal CMS Open Payments database.

$3,407 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ANNAMALAI's primary funding source is ABBOTT LABORATORIES, which accounts for $3,247 (representing 95.3% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ABBOTT LABORATORIES

Rank 1

$3,247

95.3%

ASTRAZENECA PHARMACEUTICALS

Rank 2

$116

3.4%

ABIOMED

Rank 3

$24

0.7%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.